Why is OpenAI considering antitrust complaint against Microsoft?
How will FDA’s new priority review vouchers affect biopharma?
Why is Tesla halting Cybertruck and Model Y production?
How does Israel-Iran conflict impact global markets?
Why is Amazon reducing its workforce due to AI?
What caused the drop in US retail sales in May?
How will Kraft Heinz’s dye removal affect product lines?
Former 23andMe CEO Outbids Big Pharma to Regain Control of DNA Testing Firm
thedailybeast.com/former-23andme-ceo-outbids-big-pharma-to-regain-control-of-dna-testing-firm
Former 23andMe CEO Anne Wojcicki is set to regain control of the genetic testing firm she led to bankruptcy after outbidding a pharmaceutical company at an auction. The sale came on Monday after a nonprofit headed by Wojcicki, TTAM Research Institute, bid $305 million for control of the…
This story appeared on thedailybeast.com, 2025-06-17 15:43:16.585000.